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Abstract
Glycine receptors (GlyRs) play important roles in regulating hippocampal neural network activity
and spinal nociception. Here we show that, in cultured rat hippocampal (HIP) and spinal dorsal horn
(SDH) neurons, 17-β-estradiol (E2) rapidly and reversibly reduced the peak amplitude of whole-cell
glycine-activated currents (IGly). In outside-out membrane patches from HIP neurons devoid of
nuclei, E2 similarly inhibited IGly, suggesting a non-genomic characteristic. Moreover, the E2 effect on
IGly persisted in the presence of the calcium chelator BAPTA, the protein kinase inhibitor
staurosporine, the classical ER (i.e. ERα and ERβ) antagonist tamoxifen, or the G-protein
modulators, favoring a direct action of E2  on GlyRs. In HEK293 cells expressing various
combinations of GlyR subunits, E2 only affected the IGly in cells expressing α2, α2β or α3β subunits,
suggesting that either α2-containing or α3β-GlyRs mediate the E2 effect observed in neurons.
Furthermore, E2 inhibited the GlyR-mediated tonic current in pyramidal neurons of HIP CA1
region, where abundant GlyR α2 subunit is expressed. We suggest that the neuronal GlyR is a novel
molecular target of E2 which directly inhibits the function of GlyRs in the HIP and SDH regions. This
finding may shed new light on premenstrual dysphoric disorder and the gender differences in pain
sensation at the CNS level.
Background
Studies over the last several decades have demonstrated
that estrogen plays an important role in not only repro-
duction, but also regulation of early CNS development [1]
and in synaptic plasticity of the mature hippocampus [2].
The classical estrogen actions in the CNS are primarily
mediated by activating nuclear estrogen receptor α and β
(ERα/β), causing long-term genomic effects [3,4]. Never-
theless, it is becoming increasingly clear that estrogen can
activate cytoplasmic signaling events at or near the plasma
membrane [5,6], presumably through either membrane-
localized classical ERs [7,8] or novel ERs [9-11]. Moreo-
ver, estradiol is reported to directly bind to and modulate
certain ion channels, like the Maxi-K channels [12], indi-
cating the existence of additional estrogen targets besides
ERs. In the hippocampus, both in vivo [13] and in vitro
[14-16] studies have focused on the inhibitory GABAergic
machineries, and suggested that estradiol alters neuronal
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activity by suppressing GABAergic synaptic transmission.
A recent study also indicated that estradiol inhibits
human recombinant rho1 GABAC receptor [17].
Like GABAA  receptors (GABAARs), the major receptor
mediating central inhibition, GlyRs contribute to neuro-
nal inhibition in hippocampus [18-20] and spinal cord
[21,22]. GlyRs are pentamers and composed of α(1–4)
and  β subunits [21]. In hippocampal (HIP) neurons,
GlyRs are thought to be primarily the homopentamer of
α2 subunits that function extrasynaptically to produce
tonic inhibition [21]. Tonic activation of GlyRs leads to
cross-inhibition of GABAARs [23], and influences synaptic
activity [18,24,25] and short-term plasticity [19]. In adult
spinal dorsal horn (SDH), GlyRs are important in regulat-
ing nociception and motor function. For example, α3-
containing GlyRs regulate inflammatory pain sensitiza-
tion [26]. Interestingly, during the development of the
spinal cord, there is a switch of GlyR subunit composition
from α2 in the fetus to α1 predominance in the adult
[21,27], suggesting a role of the α2 subunit in neuronal
development. Indeed, two recent studies showed that
GlyRs play an important role in rod photoreceptor devel-
opment of the vertebrate retina [28] and regulate spinal
interneuron differentiation in zebrafish [29]. On the other
hand, estrogen is locally synthesized in the CNS [30] and
the level of estrogen is under regulation [1,31]. A recent
study showed that estradiol enhances the spontaneous
synaptic release of glycine in hypoglossal motoneurones
[32]. However, the estradiol effects on GlyRs remain unex-
plored. In this study, therefore, we examined the modula-
tory effects of 17-β-estradiol (E2), the most prevalent and
potent form of endogenous estrogen, on native GlyRs in
HIP and SDH neurons, and on recombinant GlyRs
expressed in HEK293 cells. This study will add a new
dimension for understanding the multifaceted estrogenic
effects in the CNS.
Results
17- -estradiol rapidly inhibits glycine-activated current 
(IGly) in cultured rat SDH and HIP neurons
At a holding potential (VH) of -50 mV under whole-cell
voltage clamp, application of glycine (100 μM) to the cul-
tured HIP or SDH neurons elicited an inward current. The
strychnine sensitivity and chloride dependence of the IGly
suggests that it was mediated by GlyR-chloride channels
(data not shown). After recording a stable control IGly, we
pre-superfused the neurons with E2 at various concentra-
tions for 30 s, and then recorded IGly in the presence of E2.
The peak amplitude of IGly was rapidly reduced by E2
application (Figure 1A), while it was not further inhibited
when the pre-perfusion time was prolonged (data not
shown). In neurons derived from neonatal rats of both
sexes, E2 exerted a similar inhibitory effect on IGly, there-
fore data from both sexes were pooled for comparison. As
shown in Figure 1B, E2 concentration-dependently inhib-
ited the peak IGly. On average, E2 at 1, 3, 6 and 10 μM sig-
nificantly reduced peak IGly to 95.0 ± 0.8% (P  < 0.05
compared with control, n = 4), 85.8 ± 2.2% (P < 0.01
compared with control, n = 5), 80.2 ± 4.0% (P < 0.01
compared with control, n = 5) and 63.4 ± 2.2% (P < 0.001
compared with control, n = 8, Paired Student's t-test for
all) of control in HIP neurons, respectively; and in SDH
neurons, peak IGly was reduced to 97.0 ± 0.9% (P < 0.05
compared with control, n = 6), 89.1 ± 2.0% (P < 0.01
compared with control, n = 7), 83.1 ± 3.0% (P < 0.01
compared with control, n = 8) and 75.3 ± 2.1% (P < 0.01
compared with control, n = 7, P < 0.01 compared with the
inhibition of 10 μM E2 produced in HIP neuron) of con-
trol, respectively. The IC50 values of E2 for IGly of the HIP
neuron and SDH neuron are 16.5 ± 2.7 μM and 33.2 ± 3.4
μM (P < 0.01 compared with that in HIP neuron), respec-
tively. Therefore E2 has stronger inhibitory effect on IGly
mediated by hippocampal GlyR. To assess possible con-
taminations of endogenous steroids derived from glial
cells [30,33], we examined the E2 effect in cultures grown
without blocking the proliferation of glial cells and found
that E2 still inhibited IGly under such a condition (data not
shown).
The concentration-effect relationships for E2 shown in Fig-
ure 1B indicate that E2 inhibited IGly more markedly in cul-
tured HIP neurons. In the following experiments,
therefore, we used HIP neurons to study the mechanisms
underlying E2 inhibition. To explore whether a genomic
mechanism is responsible for E2 inhibition on IGly, we first
examined the effect of E2 in large outside-out patches
excised from cultured HIP neurons. The patches were
exposed to rapid changes of glycine or glycine plus E2. As
shown in Figure 1C, the peak amplitude of IGly was signif-
icantly inhibited by E2 (59.2 ± 3.6% of control, P < 0.001,
Paired Student's t-test). Since outside-out patches contain
no cellular nuclei, this result indicates that E2 inhibited
IGly via a non-genomic mechanism. We next examined the
concentration-response relationships of IGly  in the
absence or presence of E2. As shown in Figure 1D, E2 at 10
μM suppressed IGly evoked by both subsaturating and sat-
urating concentrations of glycine. The EC50 and Hill coef-
ficient of glycine were 42.9 ± 4.3 μM and 1.7 in the
absence of E2 and 61.7 ± 8.1 μM and 1.2 in the presence
of E2, respectively. This result suggests that E2 inhibits IGly
in a noncompetitive manner.
No involvement of intracellular signaling pathways and 
classical ERs
Previous studies have indicated that the acute effect of E2
occurring within a time course of milliseconds to minutes
are attributed to the activation of intracellular signaling
pathways mediated by presumably membrane-bound
classical ERs [7,8,34,35] or novel ERs [9,10]. Additionally,Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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E2-induced inhibition of IGly in cultured SDH and HIP neurons Figure 1
E2-induced inhibition of IGly in cultured SDH and HIP neurons. (A) Representative traces of current induced by 100 
μM glycine in the presence or absence of E2 at various concentrations in cultured HIP (upper) and SDH (bottom) neurons. The 
neurons were pre-treated with E2 for 30 s before E2 and glycine were co-applied. (B) Summarized data illustrating the concen-
tration dependence of E2 inhibition (n = 4–8) as shown in A. (C) E2 significantly inhibited IGly recorded from the outside-out 
patches (n = 5). The upper traces show the representative IGly recorded from outside-out patches in the presence and absence 
of E2. ***P < 0.001, Paired Student's t-test, compared with control without adding E2. (D) The concentration-response curves 
of IGly in the presence and absence of 10 μM E2. For each neuron recorded, the current was normalized to the peak amplitude 
of IGly induced by 100 μM glycine alone (P) from the same neuron and each point represents the average value of 5–9 neurons.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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E2 can modulate calcium channels and affect the intracel-
lular calcium level [36,37]. To explore the possible
involvement of any intracellular pathways in mediating E2
inhibition of IGly, following experiments were conducted.
We first examined the role of the intracellular Ca2+. When
neurons were loaded with 15 mM BAPTA via the record-
ing pipette, E2 reduced the peak IGly to 62.7 ± 2.0% of the
control, which was not significantly different from that
obtained in the absence of BAPTA (Figure 2A1 and 2B1, P
> 0.05, Unpaired Student's t-test). In order to test the role
of protein phosphorylation and dephosphorylation in E2
inhibition, we loaded the neurons with staurosporine (5
μM), a nonselective protein kinase inhibitor, to disrupt
the balance between phosphorylation and dephosphor-
ylation. Likewise, the inhibitory effect of E2 on IGly was not
altered (Figure 2A2 and 2C1, P > 0.05, Unpaired Student's
t-test). A previous study [38] demonstrated that the GlyR
is a target of the G protein βγ dimer. To examine the role
of G proteins, we loaded the neurons with GTP-γ-S (500
μM) or GDP-β-S (500 μM) to activate or block the G pro-
tein, respectively. Neither of these treatments affected the
inhibition induced by E2 on IGly (Figure 2A3, A4, and 2C,
P > 0.05, Unpaired Student's t-test). Thus, it is unlikely
that E2 exerts its inhibition on IGly through intracellular
signaling pathways.
We further employed tamoxifen, a classical ER antagonist
in the hippocampus [15], to examine whether membrane-
localized classical ERs were involved in E2 inhibition of
IGly. After incubation of 1 μM tamoxifen for 2 h, we exam-
ined the effects of E2on IGly in the continued presence of
tamoxifen. Though, consistent with the previous study
[32], the peak amplitude of IGly induced by 100 μM gly-
cine was decreased after the treatment with tamoxifen
(Figure 2A5, note the difference in the scale bar), the
inhibitory effect of E2 on IGly was not affected (Figure 4A5
and 4B1, P > 0.05, Unpaired Student's t-test). Moreover,
17-α-estradiol (17-α-E2, 10 μM), the inactive stereoisomer
of E2, mimicked the inhibitory effect of E2 on IGly (Figure
2A6 and 2B1, P > 0.05, Unpaired Student's t-test), suggest-
ing that E2 inhibition on GlyR is independent of classical
ERs.
Regulatory sites for E2 and pregnanolone on GlyRs are 
separate
A previous study showed that another neurosteroid, preg-
nanolone (PGN) directly inhibited IGly in a competitive
manner [39]. We were interested to know whether E2 and
PGN share a common binding site on GlyRs. If the sites
are separate, the inhibitory effects should be additive
when E2 and PGN were co-applied. As shown in Figure 3A,
PGN at 1 μM and 10 μM significantly inhibited the peak
amplitude of IGly by 25.1 ± 7.6% and 49.0 ± 5.9% of con-
trol, respectively. In the presence of 10 μM E2, additional
inhibition of IGly was observed by PGN at both 1 μM (Fig-
ure 3B, 51.3 ± 5.3% of control), and 10 μM (Figure 3B,
70.4 ± 7.3% of control). These data suggest that distinct
binding sites may mediate the inhibition of E2 and PGN
on IGly.
Subunit selectivity of E2 inhibition on GlyRs
To determine which GlyR subunits are responsible for the
E2-induced inhibition, we investigated the E2 effects on
IGly  in HEK293 cells expressing various recombinant
GlyRs (Figure 4A). In GlyR subunit-untransfected cells, no
glycine responses were observed (data not shown). As
shown in Figure 4, E2 selectively inhibited the peak IGly
mediated by homomeric α2-GlyRs to 75.1 ± 4.3% of con-
trol (P < 0.001, n = 6, Paired Student's t-test), but had no
significant effect on homomeric α1- and α3-GlyRs (99.8 ±
3.1% of control and 99.0 ± 1.2% of control for α1- and
α3-GlyRs, respectively, P > 0.05, n = 10, Paired Student's
t-test). To further examine whether co-expression of β sub-
unit affected the E2 inhibition, we tested the inhibitory
effect of E2 on heteromric GlyRs. We found that E2 inhib-
ited the peak IGly mediated by α2β – and α3β-GlyRs to
78.9 ± 2.9% (P < 0.001, n = 9, Paired Student's t-test) and
71.0 ± 3.0% of control (P < 0.001, n = 11, Paired Student's
t-test), respectively. However, IGly mediated by α1β-GlyRs
was not significantly affected. Thus, it is likely that either
α2- or α2β – or α3β-GlyRs mediate the E2 effect in SDH
and HIP neurons.
The developmental changes of E2 inhibition of GlyRs in 
spinal cord neurons
The GlyR subunit expression is developmentally regulated
in some areas of CNS such as spinal cord. To test whether
E2 effects are different in different times in culture, we
investigate the effects of E2 on GlyR in spinal cord and HIP
neurons from different days in culture. We first recorded
IGly in cultured HIP neurons after different days of in vitro
(DIV) differentiation. As shown in Figure 5, the inhibitory
extent of E2 on IGly did not change with time in vitro (P >
0.05, comparing DIV6–8, 13–15 and 20–23, n = 5–7, one-
way ANOVA). We next examined the effects of E2 on IGly
induced by 100 μM glycine of spinal cord neurons in cul-
tures after DIV6–8, 13–15 and 20–23. Interestingly, E2 sig-
nificantly inhibited IGly of the neurons at DIV6–8 and 13–
15, but the inhibitory effects declined in the neurons at
DIV20–23 (P = 0.012, comparing between DIV20–23 and
DIV6–8; P = 0.023, comparing between DIV20–23 and
DIV13–15. n = 6–8, one-way ANOVA).
Inhibitory effect of E2 on GlyR-mediated tonic current in 
HIP slices
In the developing and mature hippocampus, α2 subunit
represents the primary component of the functional
GlyRs [21]. This unique property enables us to examine
the action of E2 on GlyRs from pyramidal neurons in CA1
region of HIP slices. Glycine concentration in cerebrospi-Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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E2-induced inhibition of IGly is independent of intracellular signaling pathways and classical estrogen receptors (ERs) Figure 2
E2-induced inhibition of IGly is independent of intracellular signaling pathways and classical estrogen receptors 
(ERs). (A) Sample traces illustrating the inhibitory effects of E2 on the peak IGly under the conditions of intracellular application 
15 mM BAPTA (A1), 5 μM staurosporine (A2), 0.5 mM GTP-γ-S (A3) and 0.5 mM GTP-β-S (A4), respectively. A5, Effect of E2 
on IGly after incubation of neurons with tamoxifen for 2 h. A6, Effect of 17-α-E2 on IGly. (B) Pooled data summarizing the effect 
of E2 on IGly under various conditions shown in A. Each column represents the average values from 4–6 neurons, ***P < 0.001, 
Paired Student's t-test, compared with control without adding E2 or 17-α-E2 (dashed line). NS indicates no significant difference 
in this and the following figures.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
Page 6 of 14
(page number not for citation purposes)
Interactions of E2 and PGN on IGly Figure 3
Interactions of E2 and PGN on IGly. (A) Sample traces illustrating the additive effect of E2 and PGN on IGly. (B) Summary of 
results from all experiments similar to those shown in A (n = 4–5). Sum (1) is the expected linear summation of the inhibition 
induced by 10 μM E2 and 1 μM PGN; Sum (2) is the expected linear summation of the inhibition induced by 10 μM E2 and 10 
μM PGN. P > 0.05, Unpaired Student's t-test.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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Inhibitory effect of E2 on recombinant GlyRs Figure 4
Inhibitory effect of E2 on recombinant GlyRs. (A) Sample traces demonstrating the effects of 10 μM E2 on various homo-
meric and heteromeric GlyRs. (B) Summary of results from all experiments similar to those shown in A. E2 selectively inhibited 
the peak amplitude of IGly mediated by α2-containing GlyRs and α3β heteromeric GlyR. Each column represents the average 
value of 6–11 neurons. ***P < 0.001, Paired Student's t-test, compared with the control without E2 treatment (dashed line).Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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nal fluid has been estimated to be in the micromolar
range [40]. In order to magnify the current, we recorded
the GlyR-mediated tonic current by adding 20 μM glycine
to ACSF in addition to the presence of GlyT1 inhibitor sar-
cosine (0.5 mM) [25]. At the same time, TTX (0.3 μM) was
added in the bath to reduce random baseline current fluc-
tuations, and 10 μM bicuculline, 10 μM DL-2-amino-5-
phosphovaleric acid (APV) and 3 μM 6-cyano-7-nitroqui-
noxaline-2,3-dione (CNQX) were added to block GABAA
and ionotropic glutamate receptors, respectively. After
recording a control period in the cocktail solution, E2 at
10 μM was superfused (Figure 6A). As shown in Figure 6B,
the GlyR-mediated tonic current was significantly reduced
to 69.3 ± 5.8% of control by E2 perfusion (P = 0.043, n =
8, Wilcoxon matched-pairs signed-ranks test), a level com-
patible with that obtained in the cultured neurons (Figure
1B) or HEK 293 cells expressing recombinant α2- and
α2β-GlyRs (Figure 4B).
Discussion
Here, we present evidence that in cultured HIP and SDH
neurons, E2 directly inhibited GlyRs which are likely com-
posed of α2 or α3 subunit. Furthermore, the GlyR-medi-
ated tonic current in HIP slices was reduced by E2. Thus,
in addition to the well-known signaling pathways of E2 via
ERs, the GlyR may be an additional central target of E2.
Since GlyRs are important regulators of spinal nocicep-
tion [26,41,42], and affect HIP network activity [19,20],
our findings may shed new light on the gender differences
in pain sensation at the CNS level.
Mechanisms underlying E2 inhibition of GlyRs
Estrogen exerts effects in the CNS primarily by activating
ERs [3]. In this study, however, several lines of evidence
suggest that E2 inhibited IGly through a direct interaction
with plasma membrane GlyRs. First, the effects of E2 are
most likely non-genomic as the inhibition occurred
within seconds following E2 application and persisted in
large outside-out patches devoid of nuclei. Second, it is
unlikely that E2 physically disrupts the plasma membrane
via a nonspecific way as E2 only affected α2 subunit-con-
taining and heteromeric α3β-GlyRs. Moreover, when E2
was applied, the membrane capacitance remained
unchanged, indicating that the membrane structure was
unaltered (see Materials and Methods). Third, E2 inhibi-
tory effect persisted in the presence of tamoxifen, the
antagonist of classical ERs [43], or 17-α-E2, the inactive
stereoisomer of E2  [44]. In addition, E2  inhibited the
recombinant GlyRs expressed in HEK293 cells which are
devoid of classical ERs [45]. Finally, in the presence of the
calcium chelator, the protein kinase inhibitor or G-pro-
tein modulators, the E2-induced inhibition remained
unchanged. These results strongly support the notion that
E2 inhibits GlyRs independent of any intracellular signal-
ing pathways activated by either classical ERs or novel ERs
[9-11].
Our data suggest that E2 inhibited IGly in a noncompetitive
manner because E2 reduced IGly independent of glycine
concentrations, and the effect can be additive with that of
PGN, a competitive steroid inhibitor of GlyR without
changing the membrane viscosity [39,46]. Two general
mechanisms may underlie the noncompetitive inhibition
of E2 on GlyR, open-channel blocker or allosteric modula-
tion. Nevertheless, E2 is not charged at physiological pH
and inhibited IGly independent of membrane potentials
(P.J. and T.L.X., unpublished data), which makes it
unlikely that E2 acts as an open-channel blocker. Thus, we
propose that E2 directly binds to and allosterically inhibits
GlyRs.
Functional implications
Generally, the physiological concentration of estradiol in
plasma is in the nanomolar range [6]. In the present
study, the concentrations at which E2 exerted significant
effects on GlyRs were much higher than its physiological
level. However, in the CNS of both male and female rats,
estrogen can be de novo synthesized and accumulated
locally [30,47], leading to E2 concentration in the cerebro-
spinal fluid far surpass those measured in plasma. For
example, a previous study has demonstrated that the con-
centration of estradiol in the hippocampus of male rats is
six-fold higher than that in plasma [48]. More interest-
Developmental regulation of E2 inhibition on IGly Figure 5
Developmental regulation of E2 inhibition on IGly. Hip-
pocampal and spinal cord neurons in culture were used for 
electrophysiological recording following 6–8, 13–15 and 20–
23 days of in vitro (DIV) differentiation to examine the devel-
opmental dependence of E2 inhibition on IGly. Each column 
represents the average value of 5–8 neurons. * P < 0.05 and 
*** P < 0.001 (Student's paired t test, n = 8), compared to 
control without adding E2; # P < 0.05 (one-way ANOVA, n = 
8), comparing DIV 20–23 with either DIV 6–8 or DIV 13–15.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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ingly, a recent study indicates that forebrain estradiol lev-
els in zebra finches are also acutely increased during social
interactions [49]. In addition, certain cofactors, like sexual
hormone-binding proteins, can make E2 to achieve an
effect even at low concentrations [50]. Therefore, it is rea-
sonable to speculate that, under certain physiological or
pathological condition, locally elevated endogenous
estrogen may have an impact on GlyRs through the proc-
ess revealed in this study.
In HEK293 cells expressing recombinant GlyRs, we found
that E2 significantly inhibited α2-GlyRs. Accumulative evi-
Inhibitory effect of E2 on GlyR-mediated tonic current in HIP slices Figure 6
Inhibitory effect of E2 on GlyR-mediated tonic current in HIP slices. (A) Left, Whole-cell voltage-clamp recording 
showing the current in the presence of 0.3 μM TTX, 10 μM bicuculline, 3 μM CNQX, 10 μM APV, 20 μM glycine and 0.5 mM 
sarcosine. Application of strychnine (2 μM) decreased the membrane current noise and revealed the tonically activated GlyR 
current. In the presence of E2 (10 μM), the amplitude of GlyR-mediated tonic current was significantly reduced. Right (a1–a3), 
Gaussian fit to all-point histograms of 30 s traces at the time point a1, a2 and a3 (A, inset). The differences among the Gaussian 
means are marked by the dotted lines. (B) The normalized GlyR-mediated tonic current in the absence or presence of E2 (n = 
8). *P < 0.05, Paired Student's t-test, compared with the control without E2 treatment.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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dence demonstrates that the α2-GlyRs distribute through-
out the developing CNS and in the mature hippocampus
[21,51,52]. In CA1 region of HIP slices, we observed that
GlyR-mediated tonic currents, which are likely mediated
by α2-GlyRs [51-53], were reduced to a level compatible
with that measured in cultured neurons or HEK 293 cells
expressing recombinant GlyRs. The tonic activation of the
α2 subunit-containing GlyRs is functionally important in
the development of the cortex [54], the retina [28] and the
spinal cord [29]. Furthermore, previous studies have
shown that GlyR subunit composition of spinal cord neu-
rons changes during development from α2 to α1 predom-
inance both in cultures and in in vivo conditions [27,55].
Because of this switch of GlyR subunit composition in the
spinal cord during development, a previous study [56]
suggested that the selective inhibition of progesterone on
α2-GlyRs endows an important role of progesterone in
the developing spinal cord. Since the levels of estrogen
fluctuate in both males and females during brain develop-
ment [31], E2-induced inhibition of GlyRs may contribute
to the modulation of estrogen on the early CNS develop-
ment. It remains unexplored whether GlyRs also partici-
pate in regulation of neuronal excitability, through E2-
induced disinhibition in the mature hippocampus [14].
Under certain disease conditions, for example, premen-
strual dysphoric disorder (PMDD), anxiety is enhanced
when neuronal excitability is disturbed during the ovarian
cycle [57]. A recent study reported that the periodic alter-
ations of the GABAAR-mediated tonic inhibition, which
resulted from the fluctuation of hormones in the hippoc-
ampus during estrous cycle, play a crucial role in altered
seizure susceptibility and anxiety during PMDD [58]. Sim-
ilar to the tonic GABAergic inhibition, GlyRs-mediated
tonic currents modulate neuronal excitation and network
function [18,19,24,25]. Our present data showed that E2
can inhibit more than 30% of the tonic IGly in hippocam-
pal slices. Therefore, the significant inhibition of IGly pro-
duced by E2  may have strong effect on the neuronal
excitability, suggesting an alternative cellular mechanism
by which periodic sex hormone fluctuations affect CNS
neuronal excitation and cause mood disorders. Consider-
ing the ubiquitous distribution profiles of GABAARs in the
CNS and the hypnotic side-effect of GABA-mimic drugs,
the present finding suggests new directions for treatment
of PMDD by using GlyR-enhancing drugs and/or glycine
reuptake inhibitors [25].
Besides, sex-related difference in pain perception has been
revealed by previous studies which indicate that noxious
stimuli are perceived as more painful by women than by
men [13,43]. Although sex hormones have been shown to
be involved in this difference, the underlying mechanisms
are still unknown. Functional α3β-GlyRs exist in inhibi-
tory synapse of SDH neurons, which is the first site for
integration, relay and modulation of nociceptive informa-
tion from nociceptor [59]. Moreover, previous studies
have suggested that α3β-GlyRs in the SDH neurons regu-
late inflammatory pain sensitization [26,41]. In this
study, we noted that E2 significantly inhibited IGly in cul-
tured SDH neurons and the current mediated by α3β-
GlyRs expressed in HEK293 cells, providing important
insights into the mechanisms underlying gender differ-
ences in pain sensation at the CNS level.
Finally, several studies indicate that the expression of high
affinity GlyR subunit α2192L and α3185L produced by RNA
editing [60] was increased in the brain after experimen-
tally induced brain lesion of rat [61] and in temporal lobe
epilepsy patient with a severe course of disease [62].
According to the selectivity of E2 inhibition on α2 and α3-
containing GlyR, E2 thus may play a role through modu-
lating these high affinity GlyRs in some pathological situ-
ations such as temporal lobe epilepsy and brain damage.
Conclusion
We demonstrated that the neuronal GlyR is a novel
molecular target of E2 which directly inhibits the function
of GlyRs in the HIP and SDH regions. Through their
impact on GlyRs in the CNS, sex hormones may regulate
neuronal excitability and contribute to premenstrual dys-
phoric disorder and sex-related pain sensation under both
physiological and pathological conditions.
Methods
The care and use of animals in these experiments followed
the guidelines of the Institutional Animals Care and Use
Committee of the Institute of Neuroscience, Shanghai
Institutes for Biological Sciences, Chinese Academy of Sci-
ences. All efforts were made to minimize the number of
animals used and their suffering.
Cell culture
Cultures of HIP neurons were prepared as previously
described [63] with some modifications. Briefly, hippoc-
ampus from neonatal (< 24-hour-old) Sprague-Dawley
rats with identified sex were dissociated in Ca2+-free saline
with sucrose (20 mM) and hippocampal neurons were
isolated using a standard enzyme treatment protocol. Cul-
tures of SDH neurons were prepared from embryonic day
15 (E15) Sprague-Dawley rats as previously described
[39]. The neurons were plated (1–5 × 105 cell/ml) on
poly-L-lysine (Sigma, USA) coated cover glasses and
grown in Dulbecco's modified Eagle's medium (DMEM,
Gibco, USA) with L-glutamine plus 10% fetal bovine
serum (Gibco). The neurons were allowed to attach the
cover glasses for 24 h, after which the medium was
changed to neuron-basal medium (1.5 ml, Gibco) with
2% B27 (Gibco) and replaced every 3–4 days. Treatment
with 5-fluoro-5'-deoxyuridine (20 μg/ml, Sigma, St.Molecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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Louis, MO) on the fourth day after plating was used to
block cell division of non-neuronal cells, which helped to
stabilize the cell population. The cultures were main-
tained at 37°C in a 5% CO2 humidified atmosphere. Cells
were used for electrophysiological recordings 7–23 days
after plating.
Slice preparation
Experiments were performed on 400 μm transverse hip-
pocampal slices from 14- to 17-day-old Sprague-Dawley
rats. After decapitation, the brain was removed and placed
in oxygenated (95% O2/5% CO2) artificial cerebrospinal
fluid (ACSF) at 4°C. Slices were cut from the dorsal hip-
pocampus with a vibratome (Leika VT 1000S) and main-
tained at room temperature (23–25°C) in a holding
chamber filled with oxygenated ACSF. After an equilibra-
tion period of at least 2 h, a single slice was transferred to
the recording chamber, where it was continuously per-
fused with oxygenated ACSF (23–25°C) at a flow rate of
2.5–3 ml/min.
Expression of recombinant GlyRs
All constructs were expressed in HEK293 cells as previ-
ously reported [39]. In brief, HEK293 cells were cultured
at 37°C in a humidified atmosphere of 5% CO2 and 95%
air. Cells were maintained in DMEM supplemented with
2 mM L-glutamine, 10% fetal bovine serum, and 100
units/ml penicillin/streptomycin (all from Invitrogen).
Transient transfection of HEK293 cells was carried out by
using the Lipofectamine 2000 reagent (Invitrogen)
according to the supplied protocol. Co-transfection with a
green fluorescent protein expression vector, pEGFP-N1,
was used to enable identification of transfected cells for
patch clamping in some experiments. When co-transfect-
ing the GlyR α and β subunits, their respective cDNAs
were combined in a ratio of 1:2 to ensure the formation of
functional heterooligomers. Taking advantage of the
insensitivity of αβ heteromeric GlyR to picrotoxin [64],
we further tested the picrotoxin sensitivity to ensure the
formation of heterooligomers. After exposure to transfec-
tion solution for 6 h, cells were washed twice using the
culture medium and used for electrophysiological record-
ings over following 16–48 h.
Solutions and drugs
The standard external solution for cultured neurons
recording contained (mM): 150 NaCl, 5 KCl, 1 MgCl2, 2
CaCl2, 10 N-hydroxyethylpiperazine-NV-2-ethanesul-
phonic acid (HEPES), 10 Glucose (pH 7.4; osmolarity
310–320 mOsm/l). The patch pipette solution for cul-
tured neurons recording was (mM): 120 KCl, 30 NaCl, 1
MgCl2, 0.5 CaCl2, 5 EGTA, 2 Mg-ATP, 10 HEPES. The
internal solution was adjusted to pH 7.2 with Tris-base.
The ACSF for slices incubation and recording was com-
posed of (mM): 126 NaCl, 2.5 KCl, 2 MgSO4, 1.25
NaH2PO4, 26 NaHCO3, 2 CaCl2 and 10 D-glucose, aer-
ated with 95% O2 and 5% CO2 at a final pH of 7.4. The
osmolarity of the ACSF was 289–295 mOsm/l. The ionic
composition of the internal solution for slice recording
was (mM): 140 CsCl, 1 MgCl2, 10 HEPES, 0.1 EGTA, 4
NaCl, 2 MgATP and 0.3 NaGTP, adjusted to pH 7.2. Drugs
used in the present experiments were purchased from
Sigma. Steroidal agents were initially dissolved as concen-
trated stock solutions in dimethylsulphoxide (DMSO)
and subsequently diluted to the desired concentration in
standard external solution. The final concentration of
DMSO employed in the experiments was always ≤ 0.1%,
which had no detectable effect on IGly in vehicle control
experiments. Other drugs were first dissolved in ion-free
water and then diluted to the final concentrations in the
standard external solution or ACSF just prior to use.
Unless otherwise indicated, drugs were applied using a
rapid application technique termed the 'Y-tube' method
throughout the experiments. This system allows a com-
plete exchange of external solution surrounding a neuron
within 20 ms [65].
Electrophysiological recordings and data analysis
Conventional whole-cell patch-clamp recording was per-
formed under voltage-clamp conditions. Patch pipettes
were pulled from glass capillaries with an outer diameter
of 1.5 mm on a two-stage puller (PP-830, Narishige,
Tokyo, Japan). The resistance between the recording elec-
trode filled with pipette solution and the reference elec-
trode was 4–6 MΩ. Membrane currents were measured
using a patch-clamp amplifier (Axon 200B, Axon Instru-
ments, Foster City, CA, USA), sampled and analyzed using
a Digidata 1320A interface and a personal computer with
Clampex and Clampfit software (Version 9.0.1, Axon
Instruments). In most experiments, 70–90% series resist-
ance was compensated. To make outside-out patch, after
obtaining the whole-cell recording configuration, the
patch was excised by carefully withdrawing the patch
pipette from the cell [66]. Additionally, in some experi-
ments that drugs were applied in pipette, the current was
measured at least 5 minutes after whole-cell configuration
was established to ensure cell dialysis [67]. Unless other-
wise indicated, the membrane potential was held at -50
mV throughout the experiment. All experiments were car-
ried out at room temperature (22–25°C).
Membrane capacitance measurements
Whole-cell voltage clamp was used to step membrane
potential from -70 to +20 mV. A cesium based pipette
solution was used to block voltage-gated potassium chan-
nels. The capacitance transient was recorded in HEK293
cell expressing α2-GlyRs in the absence or presence of 10
μM E2. According to the calculation method of capaci-
tance provided by the previous study [46], the capacitance
of HEK293 cell expressing α2-GlyRs was estimated to beMolecular Pain 2009, 5:2 http://www.molecularpain.com/content/5/1/2
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33.3 ± 2.2 pF and 33.2 ± 2.4 pF in the absence or presence
of E2, respectively. The membrane capacitance was not
changed by E2, indicating that the alteration of plasma
membrane capacitance was not involved in E2 inhibition
of GlyRs.
Data analysis
Clampfit software was used for data analysis. The contin-
uous theoretical curves for concentration-response rela-
tionship of glycine in the presence or absence of steroids
were drawn according to a modified Michaelis-Menten
equation by the method of least-squares (the Newton-
Raphson method) after normalizing the amplitude of the
response:
I = Imax Ch/(Ch + EC50 
h)
where I is the normalized value of the current, Imax the
maximal response, C the drug concentration, EC50 the
concentration which induced the half-maximal response
and h the apparent Hill coefficient. The curve for the effect
of E2 on IGly was fitted using the following equation:
I = Imax (IC50)h/(Ch + IC50 
h)
where IC50 represents the concentration that induced the
half-maximal inhibitory effect.
For analysis of the GlyR-mediated tonic currents in HIP
slices, all-point histograms of 30 s epochs at period a1, a2
and a3 was used to measure the baseline current in differ-
ent condition of drug application (see Figure 6A), and a
Gaussian distribution was fitted to the histogram at
period a1, a2 and a3. The GlyR-mediated tonic current
was revealed by strychnine application. Therefore, the dif-
ference between the means of the fitted Gaussians at
period a1 and a3 represents the GlyR-mediated tonic cur-
rent in the absence of E2. Similarly, the difference between
period a2 and a3 represents the GlyR-mediated tonic cur-
rent in the presence of E2.
The statistical comparisons were carried out by using Stu-
dent's  t-test for two groups' comparison, and one-way
analysis of variance (ANOVA) for multiple comparisons.
All data were reported as the mean ± standard error
(S.E.M.). P and n represent the value of significance and
the number of neurons, respectively. Statistically signifi-
cant differences were assumed as P < 0.05.
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